{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:27:27Z","timestamp":1788362847335,"version":"build-2803163510"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.12252","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T15:31:57Z","timestamp":1596727917000},"page":"e2012252","source":"Crossref","is-referenced-by-count":83,"title":["Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment"],"prefix":"10.1001","volume":"3","author":[{"given":"Ihab","family":"Hajjar","sequence":"first","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Division of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Okafor","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"McDaniel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Obideen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Dee","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Shokouhi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshed A.","family":"Quyyumi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Levey","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Neurology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"issue":"6","key":"zoi200465r1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.","volume":"321","author":"Williamson","year":"2019","journal-title":"JAMA"},{"key":"zoi200465r2","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1097\/01.hjh.0000549367.55414.86","article-title":"A15294 Effects of antihypertensive therapy on cognitive function and health-related quality of life in high-risk hypertensive patients.","volume":"36","author":"Ma","year":"2018","journal-title":"J Hypertens"},{"issue":"5","key":"zoi200465r3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jash.2012.08.004","article-title":"Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function.","volume":"6","author":"Gorelick","year":"2012","journal-title":"J Am Soc Hypertens"},{"issue":"10","key":"zoi200465r4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/jch.2005.7.issue-10","article-title":"Hypertension and cognitive decline: impact on executive function.","volume":"7","author":"Vicario","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"zoi200465r5","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jalz.2010.04.005","article-title":"Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer\u2019s disease.","volume":"7","author":"Marshall","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"1-2","key":"zoi200465r6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jns.2009.09.017","article-title":"Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.","volume":"288","author":"Moorhouse","year":"2010","journal-title":"J Neurol Sci"},{"issue":"6","key":"zoi200465r7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jama.2019.10551","article-title":"Association of intensive vs standard blood pressure control with cerebral white matter lesions.","volume":"322","author":"Nasrallah","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"zoi200465r8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-018-1262-x","article-title":"RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial.","volume":"15","author":"Ahmed","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"9","key":"zoi200465r9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1111\/jgs.2015.63.issue-9","article-title":"Modulation of renin-angiotensin system may slow conversion from mild cognitive impairment to Alzheimer\u2019s disease.","volume":"63","author":"Wharton","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"zoi200465r10","doi-asserted-by":"publisher","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"zoi200465r11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2016.05.003","article-title":"Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.","volume":"624","author":"Zhuang","year":"2016","journal-title":"Neurosci Lett"},{"issue":"7","key":"zoi200465r12","doi-asserted-by":"publisher","first-page":"R131","DOI":"10.1530\/EC-17-0161","article-title":"Update on angiotensin II: new endocrine connections between the brain, adrenal glands and the cardiovascular system.","volume":"6","author":"Leenen","year":"2017","journal-title":"Endocr Connect"},{"issue":"9","key":"zoi200465r13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/0929866524666170728144801","article-title":"Brain angiotensin ii involvement in chronic mental disorders.","volume":"24","author":"Basmadjian","year":"2017","journal-title":"Protein Pept Lett"},{"issue":"5","key":"zoi200465r14","first-page":"RA155","article-title":"Is angiotensin-II an endogenous pro-inflammatory molecule?","volume":"11","author":"Das","year":"2005","journal-title":"Med Sci Monit"},{"issue":"3","key":"zoi200465r15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.neuroscience.2008.06.023","article-title":"Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats.","volume":"155","author":"Kumaran","year":"2008","journal-title":"Neuroscience"},{"issue":"2","key":"zoi200465r16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00213-012-2913-8","article-title":"Effect of angiotensin II on spatial memory, cerebral blood flow, cholinergic neurotransmission, and brain derived neurotrophic factor in rats.","volume":"226","author":"Tota","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"zoi200465r17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"zoi200465r18","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1476-5381.2010.01167.x","article-title":"Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.","volume":"163","author":"Horiuchi","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"4","key":"zoi200465r19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.109.147843","article-title":"Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.","volume":"55","author":"Rompe","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"zoi200465r20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jgs.2013.61.issue-2","article-title":"Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.","volume":"61","author":"Hajjar","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"20","key":"zoi200465r21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"1-2","key":"zoi200465r22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jns.2010.08.051","article-title":"The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke.","volume":"299","author":"Dong","year":"2010","journal-title":"J Neurol Sci"},{"issue":"4","key":"zoi200465r23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/jgs.2005.53.issue-4","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"zoi200465r24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.17116\/jnevro201511511172-79","article-title":"[Comprehensive early diagnosis of cognitive impairment].","volume":"115","author":"Lobzin","year":"2015","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"zoi200465r25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.psychres.2016.12.037","article-title":"Characterizing cognitive inhibitory deficits in mild cognitive impairment.","volume":"251","author":"Borella","year":"2017","journal-title":"Psychiatry Res"},{"issue":"1","key":"zoi200465r26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1076\/clin.15.1.109.1906","article-title":"Memory and motor skill components of the WAIS-III Digit Symbol-Coding subtest.","volume":"15","author":"Kreiner","year":"2001","journal-title":"Clin Neuropsychol"},{"issue":"2","key":"zoi200465r27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/arclin\/18.2.153","article-title":"The reliability of cluster and switch scores for the Controlled Oral Word Association Test.","volume":"18","author":"Ross","year":"2003","journal-title":"Arch Clin Neuropsychol"},{"issue":"4","key":"zoi200465r28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/WAD.0b013e3181e2fc84","article-title":"Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease.","volume":"24","author":"Teng","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"3","key":"zoi200465r29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an indicator of organic brain damage.","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"issue":"3","key":"zoi200465r30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S1355617709090626","article-title":"Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition\/interference control, and visuomotor abilities.","volume":"15","author":"S\u00e1nchez-Cubillo","year":"2009","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"zoi200465r31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1017\/S1355617713001185","article-title":"Special series introduction: NIH EXAMINER and the assessment of executive functioning.","volume":"20","author":"Kramer","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"zoi200465r32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1355617713001094","article-title":"NIH EXAMINER: conceptualization and development of an executive function battery.","volume":"20","author":"Kramer","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"zoi200465r33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1355617713001094","article-title":"NIH EXAMINER: conceptualization and development of an executive function battery.","volume":"20","author":"Kramer","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"1","key":"zoi200465r34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1037\/0022-006X.56.1.123","article-title":"Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test.","volume":"56","author":"Delis","year":"1988","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"zoi200465r35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/geronj\/47.3.P154","article-title":"Boston Naming Test: shortened versions for use in Alzheimer\u2019s disease.","volume":"47","author":"Mack","year":"1992","journal-title":"J Gerontol"},{"issue":"4","key":"zoi200465r36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1212\/WNL.62.4.556","article-title":"Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia.","volume":"62","author":"Canning","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"zoi200465r38","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: a self-report depression scale for research in the general population.","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"issue":"3","key":"zoi200465r39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living.","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"issue":"4","key":"zoi200465r40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/(ISSN)1531-8257","article-title":"Executive dysfunction using behavioral assessment of the dysexecutive syndrome in Parkinson\u2019s disease.","volume":"23","author":"Kamei","year":"2008","journal-title":"Mov Disord"},{"issue":"2","key":"zoi200465r41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/WNN.0b013e318192cd08","article-title":"Behavioral assessment of the dysexecutive syndrome battery (BADS) in schizophrenia: a pilot study in the Spanish population.","volume":"22","author":"Vargas","year":"2009","journal-title":"Cogn Behav Neurol"},{"issue":"5","key":"zoi200465r42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0895-4356(97)00010-3","article-title":"Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method.","volume":"50","author":"Schuit","year":"1997","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi200465r43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0895-4356(93)90053-4","article-title":"The Physical Activity Scale for the Elderly (PASE): development and evaluation.","volume":"46","author":"Washburn","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi200465r44","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1016\/j.neuroimage.2011.11.032","article-title":"An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis.","volume":"59","author":"Schmidt","year":"2012","journal-title":"Neuroimage"},{"key":"zoi200465r45","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"5","key":"zoi200465r46","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1001\/archinternmed.2011.1391","article-title":"Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial.","volume":"172","author":"Hajjar","year":"2012","journal-title":"Arch Intern Med"},{"issue":"3","key":"zoi200465r47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials.","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"issue":"1","key":"zoi200465r48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13195-017-0255-9","article-title":"Memory is preserved in older adults taking AT1 receptor blockers.","volume":"9","author":"Ho","year":"2017","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"zoi200465r49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer\u2019s disease: a meta-analysis of individual participant data from prospective cohort studies.","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol"},{"issue":"1","key":"zoi200465r50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurol"},{"issue":"5","key":"zoi200465r51","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/HYPERTENSIONAHA.118.11775","article-title":"Pleiotropic benefits of the angiotensin receptor blocker candesartan in a mouse model of Alzheimer disease.","volume":"72","author":"Trigiani","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"zoi200465r52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0169-328X(98)00079-5","article-title":"Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves.","volume":"57","author":"Gallinat","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"zoi200465r53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jacc.2004.03.065","article-title":"Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.","volume":"44","author":"Schieffer","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1 Pt 2","key":"zoi200465r54","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1161\/01.HYP.35.1.501","article-title":"Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension.","volume":"35","author":"Ghiadoni","year":"2000","journal-title":"Hypertension"},{"issue":"13","key":"zoi200465r55","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/jnr.22441","article-title":"An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats.","volume":"88","author":"Oyama","year":"2010","journal-title":"J Neurosci Res"},{"issue":"7","key":"zoi200465r56","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1161\/01.STR.0000129788.26346.18","article-title":"Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats.","volume":"35","author":"Ando","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"zoi200465r57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13854040490507172","article-title":"Executive impairments predict functional declines in vascular dementia.","volume":"18","author":"Boyle","year":"2004","journal-title":"Clin Neuropsychol"},{"key":"zoi200465r37","volume-title":"WMS-R: Wechsler Memory Scale\u2014Revised: Manual","author":"Wechsler","year":"1987"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2769104\/hajjar_2020_oi_200465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T07:57:27Z","timestamp":1723363047000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2769104"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.12252","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]}}}